show that resistin, a well-known uremic toxin, is significantly elevated during AKI and by itself can reproduce AKI-like neutrophil dysfunction. Finally, we provide evidence that neither conventional CVVHDF nor IHD can correct plasma resistin levels and restore normal transwell migration during AKI.
Objectives: To assess the reversibility of acute kidney injury-induced neutrophil dysfunction and to identify involved mechanisms. Design: Controlled laboratory experiment and prospective observational clinical study. Setting: University laboratory and hospital. Subjects: C57BL/6 wild-type mice. Patients: Patients with septic shock with or without acute kidney injury. Interventions: Murine acute kidney injury was induced by intraperitoneal injections of folic acid (nephrotoxic acute kidney injury) or by IM injections of glycerol (rhabdomyolysis-induced acute kidney injury). After 24 hours, we incubated isolated neutrophils for 3 hours in normal mouse serum or minimum essential medium buffer. We further studied the effects of plasma samples from 13 patients with septic shock (with or without severe acute kidney injury) on neutrophilic-differentiated NB4 cells. Measurements and Main Results: Experimental acute kidney injury significantly inhibited neutrophil migration and intracellular actin polymerization. Plasma levels of resistin, a proinflammatory cytokine and uremic toxin, were significantly elevated during both forms of acute kidney injury. Incubation in serum or minimum essential medium buffer restored normal neutrophil function. Resistin by itself was able to induce acute kidney injury-like neutrophil dysfunction in vitro. Plasma resistin was significantly higher in patients with septic shock with acute kidney injury compared with patients with septic shock alone. Compared with plasma from patients with septic shock, plasma from patients with septic shock and acute kidney injury inhibited neutrophilic-differentiated NB4 cell migration. Even after 4 days of renal replacement therapy, plasma from patients with septic shock plus acute kidney injury still showed elevated resistin levels and inhibited neutrophilic-differentiated NB4 cell migration. Resistin inhibited neutrophilic-differentiated NB4 cell migration and intracellular actin polymerization at concentrations seen during acute kidney injury, but not at normal physiologic concentrations. Conclusions: Acute kidney injury-induced neutrophil dysfunction is reversible in vitro. However, standard renal replacement therapy does not correct this defect in patients with septic shock and acute kidney injury. Resistin is greatly elevated during acute kidney injury, even with ongoing renal replacement therapy, and is sufficient to cause acute kidney injury-like neutrophil dysfunction by itself. (Crit Care Med 2016; 44:e492-e501) Key Words: acute kidney injury; neutrophils; resistin; septic shock A cute kidney injury (AKI) develops in more than 50% of critically ill patients (1, 2) . Increasing epidemiological evidence supports the notion that AKI is an independent risk factor for mortality, that is, patients are dying because of and not simply with AKI (1, 3, 4) . AKI at all stages does affect not only survival but also other relevant outcomes, including length of hospital stay, readmission rates, and development of end-stage kidney disease (5, 6) .
Despite a wealth of data demonstrating worse outcomes in patients with AKI, the exact underlying mechanisms remain largely unknown.
Research efforts over the past decade have shown that AKI is a systemic disease. The interactions between AKI and the immune system have become a particular focus of research activities, largely experimental studies. These efforts have been further fueled by findings of higher infection rates in patients with AKI (7-9), for example, bacteremia, infections after cardiac surgery, and infections in patients with hematologic malignancies. Infections are a particular problem for patients on renal replacement therapy (RRT) (10, 11) . Nearly 50% of all infections become apparent shortly before initiation of RRT, 40% during RRT, and approximately 10% in the period following discontinuation of RRT. Unfortunately, RRT does not seem to alter the AKI-associated risk of infection (10, 11) .
We have recently shown in various animal models and in a small clinical study that AKI inhibits crucial steps within the leukocyte recruitment cascade, especially slow leukocyte rolling and transmigration (12) (13) (14) . We have further shown that AKI-induced impairment of neutrophil recruitment worsens bacterial pneumonia (14) .
The effects of AKI on neutrophils appear to be mediated by intracellular changes in actin polymerization and phosphorylation of signaling pathways (13, 14) .
We have also demonstrated that neutrophils from patients with sepsis-induced AKI lack slow rolling, when compared with neutrophils from patients with sepsis but without AKI (13) .
AKI-induced renal endocrine failure is characterized by drastically reduced 1,25-dihydroxyvitamin D3 levels (15, 16) . 1,25-dihydroxyvitamin D3 activates intracellular signaling pathways, which in turn are crucial for appropriate cytoskeleton rearrangement and cell recruitment (17, 18) .
In addition to electrolyte, fluid, and acid-base disturbances, AKI-induced renal exocrine failure also leads to accumulation of various uremic toxins, some of which impair leukocyte function. RRT fails to remove some of these toxins effectively (19) (20) (21) .
We now present a translational approach to assess the reversibility of AKI-induced neutrophil dysfunction under both experimental and clinical conditions. In particular, we have examined whether restoration of renal exocrine and/or endocrine function is necessary to correct neutrophil dysfunction in vitro.
Guided by findings from the first part of our study, we have then sought to identify potential mediators involved in AKIinduced neutrophil dysfunction.
MATERIALS AND METHODS

Animals
The Animal Care and Use Committee of the Penn State College of Medicine approved all animal experiments. We used 10-to 12-week-old male wild-type C57BL/6 mice. Mice were housed in a barrier facility under specific pathogen-free conditions.
Human Subjects
The University of Pittsburgh Institutional Review Board approved the study. After informed consent, blood was drawn from eight patients with septic shock and from five patients with septic shock plus AKI. In patients with AKI, we collected blood immediately before initiation of RRT (five continuous venovenous hemodiafiltration) and on day 4 of RRT (four continuous venovenous hemodiafiltration, one intermittent hemodialysis). RRT mode and intensity was at the discretion of the attending nephrologist. Septic shock was defined according to the American College of Chest Physicians/Society of Critical Care Medicine consensus conference criteria (22) . AKI was defined according to the Risk, Injury, Failure, Loss, and End-stage Kidney (RIFLE) criteria; only patients with RIFLE-Failure were included (23) . We excluded patients who were pregnant, younger than 18 years, already receiving RRT, receiving immunosuppressive therapy, or with a history of hematologic malignancy.
Reagents
If not stated otherwise, we obtained all reagents from Sigma-Aldrich (St. Louis, MO).
Folic Acid-Induced AKI Following our recently published protocol (14) , we used intraperitoneal (IP) injections of folic acid (FA) (450 mg/kg dissolved in NaHco 3 ) to induce nephrotoxic AKI. Sham injections of NaHco 3 served as control. Animals were exsanguinated under deep anesthesia 24 hours later.
Rhabdomyolysis-Induced AKI
As described previously (14) , we injected mice with glycerol (6 mg/kg) IM to induce rhabdomyolysis-induced (rhabdomyolysis) AKI. IM injections of normal saline served as sham intervention (control). Animals were exsanguinated under deep anesthesia 4 or 24 hours later.
In both models of AKI, we measured plasma creatinine and cystatin C to assess renal function as well plasma levels of resistin, using commercially available assays (BioVision, Milpitas, CA; R&D Systems, Minneapolis, MN).
Neutrophil Isolation
Neutrophils were isolated from bone marrow cells of exsanguinated animals by Percoll gradient as described previously (14) .
We used isolated neutrophils for either immediate transwell migration assays and intracellular F-actin measurements or reconstitution experiments (see below).
In Vitro Reconstitution Experiments
For in vitro reconstitution, we incubated neutrophils in normal mouse serum or in minimal essential medium (MEM) buffer (Life Technologies, Grand Island, NY) for 3 hours (37°C; 5% Co 2 ). Compared with normal serum, MEM does not contain any proteins, lipids, growth factors, or vitamin D3.
Our preliminary studies had shown that prolonged incubations in simple salt-buffered solutions resulted in overt cell death, excluding these buffers from further use (data not shown). Following 3-hour incubations, we assessed transwell migration and intracellular actin polymerization of the reconstituted neutrophils.
Transwell Migration Assays-Murine Neutrophils
As recently described (14) , transwell migration of murine neutrophils was evaluated using 3-μm transwell chambers coated with fibrinogen in a chemotaxis assay. Migration without N-formyl-l-methionyl-l-leucyl-l phenylalanine (fMLP) or toward fMLP was allowed for 1 hour (37°C; 5% Co 2 ). All samples were run in triplicates. Transwell migration rates were calculated as the ratio of the number of cells in the lower chamber to the number of cells seeded in the upper chamber prior to migration. Cells were counted using flow cytometry (BD Accuri C6 flow cytometer; BD Biosciences, San Jose, CA, http:// static.bdbiosciences.com/documents/accuri/Accuri-TB-Guideto-Absolute-Counting.pdf). Results were calculated as percent of sample (sham control) to normalize for assay variability (24) .
A subset of isolated neutrophils from untreated animals was incubated in phosphate-buffered saline (PBS) with or without 40 ng/mL of recombinant mouse resistin (R&D Systems) for 1 hour (37°C; 5% Co 2 ) prior to transwell migration.
Intracellular F-Actin Measurements-fMLP-Induced Actin Polymerization
Isolated murine neutrophils or neutrophilic-differentiated NB4 cells (NB4 PMN , see below) were incubated in PBS with 100 μM fMLP to initiate actin polymerization. Actin polymerization was stopped after 0, 30, 120, or 600 seconds in a simultaneous fixation, permeabilization, and staining (FPS) step (25) . FPS buffer contained 4% formaldehyde in PBS (Boston BioProducts, Ashland, MA), 1% Triton X-100, and 150 nM AlexaFluor 647 phalloidin (25) . After incubation with FPS, 500 μL of Tris (hydroxymethyl) aminomethane-buffered-saline (TBS) was added, and the cells were washed for 5 minutes. Cells were then resuspended in 500 μL of TBS and kept at 4°C until flow cytometry (BD Accuri C6 flow cytometer; BD Biosciences).
Murine neutrophils were gated by staining for a neutrophil-specific surface antigen (Ly6-G) and by their usual appearance in forward (FSC) and side scatter (SSC). NB4 PMN cells were gated by surface staining for CD11b, CD35, and CD71, as well as their appearance in FSC and SSC (26) . Median fluorescence intensity (MFI) was measured on at least 10,000 cells per sample. Flow cytometry data analysis was performed with FCS Express 4 (De Novo Software, Glendale, CA).
To account for different F-actin baseline levels in murine neutrophils with or without AKI, we calculated the area under the curve (AUC) for F-actin formation from 0 to 30 seconds (AUC 0-30″ ) for each murine sample (linear trapezoidal rule) (27) .
The product of baseline MFI × 30 seconds was subtracted from all raw AUC 0-30″ .
Intracellular F-Actin Immunofluorescence
Isolated murine neutrophils were incubated in PBS with or without 100 μM fMLP on fibrinogen-coated glass bottom microwell petri dishes (Mat Tek, Ashland, MA). Actin polymerization was stopped after 150 seconds using FPS buffer (see above, except for AlexaFluor 488 Phalloidin instead of Alexa-Fluor 647 phalloidin). Fluorescence images of the cells were obtained with a Nikon TE2000 microscope using a 60× objective, the Photo Fluor II (89 North, Burlington, VT) for illumination, an Orca-ER 1394 digital CCD camera (Hamamatsu Photonics, Bridgewater, NJ), and iVision software (Biovision Tech, Exton, PA) for acquisition. The images were processed and pseudocolored with iVision software.
Neutrophilic Differentiation of NB4 Acute Promyelocytic Leukemia Cells
We used NB4 PMN cells to study the effect of plasma from septic patients with or without AKI on neutrophil function in a standardized and reproducible way.
We induced neutrophilic differentiation by incubating NB4 cells (Part #H02129; National Cell Culture Center, Minneapolis, MN) with 1 μM all-trans retinoic acid (ATRA) for 6 days in Roswell Park Memorial Institute 1640 with 10% heat-inactivated fetal bovine serum and 1% penicillin-streptomycin. ATRA has been shown to induce differentiation of NB4 cell lines into morphologically mature neutrophilic granulocytes (26, 28) .
Successful differentiation into neutrophilic granulocytes prior to each experiment was tested by flow cytometry analysis of cell surface expression of CD11b, CD35, and CD71 before each assay (29) . Our preliminary functional studies have shown that NB4 PMN exhibited transwell migration toward fMLP as well as intracellular actin polymerization similar to that of freshly isolated human neutrophils (data not shown).
For some experiments, NB4 PMN cells were incubated for 1 hour in human control serum spiked with different concentrations of recombinant human resistin (20, 50, or 100 ng/mL) prior to further studies.
Transwell Migration Assays-NB4 PMN Cells
NB4 PMN cells were incubated in human control serum or patients samples for 1 hour prior to transwell migration assay. Transwell migration of NB4 PMN cells was evaluated using 5-μm transwell chambers coated with fibrinogen in a chemotaxis assay. Migration without fMLP or toward fMLP was allowed for 2 hours (37°C; 5% Co 2 ). The migrated cells in the bottom well were counted via flow cytometry. All samples were run in triplicates. Transwell migration of NB4 PMN cells was calculated as ratio of the cell concentration in the lower chamber and the concentrations of cells seeded in the upper chamber prior to migration. Final results are presented as transwell migration ratio of NB4 PMN cells incubated in patient serum samples normalized to that of NB4 PMN cells simultaneously incubated in human control serum.
Statistics
All data are presented as median (interquartile range). Statistical analysis included, where indicated, test for normality (Shapiro-Wilks), paired and unpaired t tests, one-way analysis of variance (ANOVA) with Tukey multiple comparisons test, two-way ANOVA with Tukey multiple comparisons test, Wilcoxon matchedpairs signed rank test, and Mann-Whitney test. A p value of less than 0.05 was considered statistically significant.
RESULTS
Nephrotoxic AKI and Rhabdomyolysis-Induced AKI
Similar to our previous study, IP injections of FA lead to nephrotoxic AKI within 24 hours (14) . AKI severity, as indicated by changes in plasma creatinine, corresponds to Kidney Disease Improving Global Outcomes (KDIGO) stage 2 in patients with AKI ( Fig. 1B) (9) . IM injections of glycerol cause rhabdomyolysis-induced AKI as early as 4 hours after injection (KDIGO stage 2) ( Fig. 1A) , lasting at least as long as 24 hours after injection (KDIGO stage 3) ( Fig. 1A) . Changes in plasma creatinine are similar to those in plasma cystatin C (Fig. 1, C and D) , supporting the use of plasma creatinine as indicator of glomerular filtration rate even in our model of rhabdomyolysis-induced AKI.
Nephrotoxic AKI and Rhabdomyolysis-Induced AKI Impair Neutrophil Transwell Migration
In agreement with our previous findings (13, 14) , rhabdomyolysis-induced AKI significantly reduces neutrophil transwell migration as early as 4 hours after induction ( Fig. 2A) . Nephrotoxic AKI does not affect neutrophil transwell migration at 4 hours (data not shown) but significantly impairs neutrophil transwell migration at 24 hours (Fig. 2B) . Both nephrotoxic and rhabdomyolysis-induced AKI attenuate neutrophil transwell migration to a similar degree.
Incubation in Buffer Reverses AKI-Induced Neutrophil Transwell Migration Defects
Three-hour incubation in normal mouse serum completely restores normal neutrophil transwell migration in rhabdomyolysis-induced AKI but only incompletely in nephrotoxic AKI (Fig. 2C) . However, a 3-hour incubation in MEM buffer fully corrects neutrophil transwell migration defects in both nephrotoxic and rhabdomyolysis-induced AKI (Fig. 2D) .
Incubation in normal serum mimics restoration of both renal exocrine and endocrine function, whereas incubation in MEM buffer only mimics restoration of renal exocrine function. Our findings, therefore, suggest that restoration of renal exocrine function is sufficient to correct AKI-induced neutrophil transwell migration defects.
Buffer Is Superior to Normal Serum for Restoring Neutrophil Transwell Migration
We performed additional statistical analyses to better understand the effects of MEM buffer and normal serum on restoration of normal neutrophil transwell migration, independent of the type of AKI. Combining all experimental data, we first grouped neutrophil transwell migration rates into quartiles (Fig. 3A) . The first quartile reflects the lowest 25% neutrophil transwell migration rates observed, whereas the fourth quartile includes the 25% highest neutrophil transwell migration rates found. This analysis shows that incubation in both normal mouse serum and buffer has little or no effect on neutrophils with the highest migration rates, that is, neutrophils in the fourth quartile (Fig. 3, B and  C) . Contrary to that, incubation in normal mouse serum or buffer greatly affects neutrophils with the lowest transwell migration rates (first quartile), that is, the neutrophils most affected by AKI. Neutrophil transwell migration rates for these cells are significantly improved. The median relative change in neutrophil transwell migration rates from before to after incubation for these cells is 1.2 and 1.7 for incubation in serum and MEM buffer, respectively. This difference in improvement of neutrophil transwell migration rates is statistically significant, indicating that MEM buffer is superior to normal serum for restoration of neutrophil function.
Incubation in Normal Serum or Buffer Corrects Actin Polymerization Defect
Our previous data have indicated that impaired neutrophil transwell migration during AKI is related to abnormal cytoskeleton rearrangement, in particular, F-actin reorganization (14) . We here further show that both nephrotoxic and rhabdomyolysis-induced AKI result in significantly lower AUC 0-30″ , indicating impaired F-actin formation (Fig. 4A ) (30, 31) . The depolymerization phase, that is, decline in F-actin, is not affected by AKI (data not shown). Incubation in either normal serum or MEM buffer corrects the AKI-induced actin polymerization defect, as there are no significant AUC 0-30″ differences between the groups. This is further evidence for a mechanistic link between impaired neutrophil transwell migration and defect actin polymerization during AKI.
Resistin Is Elevated During AKI and Sufficient to Reproduce AKI-Like Effects in Murine Neutrophils In Vitro
Both rhabdomyolysis-induced AKI and nephrotoxic AKI lead to elevated plasma resistin concentrations, exceeding 40 ng/mL at times (Fig. 5, A and B) . Plasma concentrations of resistin are elevated as early as 4 hours after induction of rhabdomyolysisinduced AKI. At this time point, impaired neutrophil transwell migration is also already present ( Fig. 2A vs Fig. 5A and Fig. 2B vs Fig. 5B) .
Further in vitro studies show that pretreatment of isolated neutrophils from untreated mice with recombinant resistin (40 ng/mL) is sufficient to reproduce the effects of AKI with respect to transwell migration (Fig. 5C) and F-actin formation (Fig. 6) . Following pretreatment, neutrophil transwell migration is impaired to a degree similar to that observed in mice with AKI ( Fig. 5C ). Also, resistin interferes with correct intracellular F-actin formation in fMLP-stimulated neutrophils comparable to that seen in mice with AKI (Fig. 6, B and D) .
Plasma From Septic Patients With AKI Inhibits Transwell Migration of NB4 PMN Cells
We collected blood samples from patients with septic shock and from patients with septic shock plus AKI (before and after 4 d of RRT). Patients with septic shock plus AKI had significantly higher serum creatinine values than patients with septic shock but without AKI (Fig. 7A) . Serum creatinine levels decreased significantly with initiation of RRT ( Fig. 7A) and were not different from those in patients without AKI. Patients with septic shock and AKI also had significantly higher plasma resistin levels (Fig. 7B) . Interestingly, RRT does not appear to significantly affect plasma resistin levels (Fig. 7B ). Plasma samples from patients with septic shock plus AKI seemingly exhibit an inhibitory effect on NB4 PMN transwell migration when compared with plasma from patients with septic shock but without AKI (Fig. 7C) . Similar to its effect on plasma resistin levels, RRT does not correct impaired transwell migration. Even after 4 days of RRT, plasma samples from patients with septic shock plus AKI still inhibit NB4 PMN transwell migration.
Resistin Inhibits NB4 PMN Function Only at Concentrations Seen During AKI
In vitro incubation of NB4 PMN cells with recombinant resistin at a physiologic concentration (32) does not cause abnormal transwell migration or F-actin formation (Fig. 8) . By contrast, recombinant resistin at concentrations seen during AKI leads to significantly reduce transwell migration and impairs F-actin formation in NB4 PMN cells (Fig. 8 ).
DISCUSSION
A growing body of evidence supports the notion that patients are dying from AKI and not simply with AKI. However, the underlying factors and mechanism remain largely unknown.
We have previously shown that AKI can affect innate immunity independent of changes to the cytokine homeostasis (12) (13) (14) . In particular, we have demonstrated that AKI inhibits crucial steps within the neutrophil recruitment cascade. Here, we present a translational study to assess the reversibility of neutrophil dysfunction and ultimately identify new potential treatment pathways. Using a nephrotoxic model and a rhabdomyolysis model of AKI, we provide evidence that AKI can impair neutrophil transwell migration as early as 4 hours after induction of AKI. These effects of AKI appear to last at least as long as 24 hours. AKI also inhibits normal intracellular F-actin formation.
Next, we sought to test whether reconstitution of either renal endocrine/exocrine function (incubation in serum) or renal exocrine function alone (incubation in MEM buffer) could reverse these defects. Our results clearly demonstrate that incubation in MEM buffer is sufficient to reverse AKIinduced neutrophil dysfunction.
Neutrophils with greatly reduced transwell migration rates benefit the most from the incubation treatment. Contrary, neutrophils with normal transmigration rates are not affected by incubation in either serum or buffer. We can, therefore, conclude that the incubation treatment actually corrects a deficiency rather than stimulates neutrophil transwell migration.
Restoration of normal intracellular actin polymerization with incubations in either normal serum or MEM buffer provides further evidence for both the concept of reversibility and a mechanistic link between actin polymerization and neutrophil transwell migration.
Originally described as a hormone causing insulin resistance, resistin is also a well-known uremic toxin and has been shown to exhibit inhibitory effects on neutrophils at concentrations seen in patients with end-stage renal disease (33) . Resistin has further emerged as an important proinflammatory cytokine that can be secreted by different cell types, including monocytes, neutrophils, and epithelial cells (34, 35) . Resistin correlates very well with disease severity, inflammatory cytokine and lactate levels, and serum creatinine concentrations in patients with severe sepsis and septic shock (36) (37) (38) . Furthermore, resistin levels appear to be higher in ICU patients with sepsis than in noninfected control patients (36) .
Here, both animal models of AKI lead to elevated plasma resistin levels at time points at which neutrophil transmigration is also impaired. Incubation of murine neutrophils or NB4 PMN cells with recombinant resistin at concentrations similar to those found in most severe forms of AKI resulted in impaired transwell migration and F-actin formation. These findings strongly suggest that resistin is sufficient to inhibit neutrophil transwell migration. The findings also support our proposed mechanistic link between impaired actin polymerization and neutrophil transwell migration.
In a small prospective, observational study, we have been able to validate key experimental findings in patients. In patients with septic shock and AKI, plasma resistin levels are significantly elevated. Furthermore, plasma resistin levels are not significantly affected by RRT. Data on the effect of RRT on plasma resistin levels are sparse. Available data suggest that intermittent hemodialysis (IHD) does not significantly affect plasma resistin levels (39) .
Plasma samples from patients with septic shock plus AKI significantly inhibit NB4 PMN transwell migration when compared with plasma samples from patients with septic shock alone. Also, our modes of RRT, continuous veno-venous hemodiafiltration (CVVHDF) and IHD, do not restore normal Figure 6 . Immunofluorescence staining for intracellular F-actin. Intracellular F-actin shows a normal pattern of distribution in neutrophils from control mice (A) or neutrophils undergoing control pretreatment (C). F-actin is primarily localized to the leading edge of the migrating cell, that is, neutrophils exhibit one short and narrow lamellipodia of F-actin at one pole of the cell (arrow). Contrary to that, F-actin localization is nearly lost in neutrophils from mice with acute kidney injury (AKI) (B) or neutrophils pretreated with resistin (D), that is, neutrophils are characterized by a lack of distinctly localized F-actin formation (arrow). No formation of a leading edge can be seen in either cell type, suggesting impaired migration of neutrophils during AKI or after pretreatment with resistin. fMLP = N-formyl-l-methionyl-l-leucyl-l phenylalanine. transwell migration. These data open a new avenue of highly interesting questions as to how resistin, a 12-kDa molecule, is cleared from the circulation and whether any modes of RRT are capable of removal. Furthermore, future efforts will also have to address the clinical relevance of elevated resistin levels in AKI and sepsis. For example, we will need studies to test the hypothesis that elevated resistin levels impair resolution of already existing infections and/or increase the risk of new infections. Ultimately, we will also need studies to assess whether removal or inhibition of resistin can improve resolution of infections and reduce the risk of new infections.
Despite its clear findings, our study has several limitations that require consideration. First and foremost, the majority of our findings are the results of in vitro experiments that require further in vivo validation regarding reproducibility and clinical relevance. Second, our experimental studies only include nephrotoxic and rhabdomyolysis-induced AKI. Both forms of AKI represent only a smaller portion of all cases of AKI seen in critically ill patients. We have, however, shown that other forms of experimental AKI, such as postischemic AKI and bilateral nephrectomy, also reduce neutrophil recruitment in vivo (12) (13) (14) . Furthermore, our previous study (13) together with the present findings validates important aspects of our experimental data in patients with septic AKI, the most prevalent form of AKI in critically ill patients (40) . In summary, our study demonstrates that removing uremic plasma and incubating neutrophils in either normal serum or MEM buffer can reverse that AKI-induced neutrophil dysfunction. This allows us to conclude that normal renal exocrine function is sufficient to restore neutrophil transwell migration in vitro. We also Figure 7 . The effects of acute kidney injury (AKI) in septic shock on plasma resistin and cell transwell migration. A, As to be expected, patients with AKI during septic shock show significantly elevated plasma creatinine concentrations when compared with those without AKI. Renal replacement therapy (RRT) significantly reduces plasma creatinine levels by day 4. B, Plasma resistin levels are also significantly elevated in patients with septic shock and AKI. Contrary to serum creatinine levels, our modes of RRT do not significantly lower plasma resistin levels. C, Neutrophilic-differentiated NB4 cells (NB4 PMN ) transwell migration is significantly reduced in patients with septic shock and AKI. RRT fails to restore normal NB4 PMN transwell migration. Figure 8 . The effects of different resistin concentrations of neutrophilic-differentiated NB4 cells (NB4 PMN ) transwell migration and intracellular F-actin formation. A, Resistin at a physiologic concentration has no effect on NB4 PMN transwell migration when compared with a resistin-free control. However, resistin at concentrations seen during (severe) acute kidney injury (AKI) significantly inhibits transwell migration (n = 8). B, Resistin at a physiologic concentration also has no effect on intracellular F-actin formation in NB4 PMN cells. By contrast, resistin at concentrations seen during (severe) AKI significantly reduces intracellular F-actin formation in NB4 PMN cells (n = 8). fMLP = N-formyl-l-methionyl-l-leucyl-l phenylalanine.
